Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF)-Reference-Cited by-同舟云学术

Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF)

Published:2010-06-10 Issue:4 Volume:30 Page:262-269
ISSN:1079-9893
Container-title:Journal of Receptors and Signal Transduction
language:en
Short-container-title:Journal of Receptors and Signal Transduction

Author:

Antoniou Katerina M.,Margaritopoulos George A.,Soufla Giannoula,Symvoulakis Emmanouil,Vassalou Evi,Lymbouridou Rena,Samara Katerina D.,Kappou Dimitra,Spandidos Demetrios A.,Siafakas Nikolaos M.

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://www.tandfonline.com/doi/pdf/10.3109/10799893.2010.489227

Reference44 articles.

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias

2. Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment

3. Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

4. Histopathologic Variability in Usual and Nonspecific Interstitial Pneumonias

5. The Prognostic Significance of the Histologic Pattern of Interstitial Pneumonia in Patients Presenting with the Clinical Entity of Cryptogenic Fibrosing Alveolitis

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. YAP/TAZ Signaling in the Pathobiology of Pulmonary Fibrosis;Cells;2024-09-10

2. Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice;Heliyon;2023-11

3. Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review;Medicine;2023-06-02

4. Optimizing antidotal treatment with the oral HSP90 inhibitor TAS-116 against hydrochloric acid-induced pulmonary fibrosis in mice;Frontiers in Pharmacology;2022-11-07

5. Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection;Expert Review of Respiratory Medicine;2022-10-03